Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleHot Topics
Open Access

61Cu-Labeled Radiotracers: Alternative or Choice?

Melpomeni Fani and Guillaume P. Nicolas
Journal of Nuclear Medicine December 2023, 64 (12) 1855-1857; DOI: https://doi.org/10.2967/jnumed.123.266171
Melpomeni Fani
1Division of Radiopharmaceutical Chemistry, University Hospital Basel, Basel, Switzerland; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guillaume P. Nicolas
2Division of Nuclear Medicine, University Hospital Basel, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 64 no. 12 1855-1857
DOI 
https://doi.org/10.2967/jnumed.123.266171
PubMed 
37884329

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication July 17, 2023
  • Revision received October 5, 2023
  • Published online December 1, 2023.

Article Versions

  • previous version (October 26, 2023 - 08:39).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2023 by the Society of Nuclear Medicine and Molecular Imaging. Immediate Open Access: Creative Commons Attribution 4.0 International License (CC BY) allows users to share and adapt with attribution, excluding materials credited to previous publications. License: https://creativecommons.org/licenses/by/4.0/. Details: http://jnm.snmjournals.org/site/misc/permission.xhtml.

Author Information

Statistics from Altmetric.com

Cited By...

  • 7 Citations
  • 8 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • 61Cu-PSMA–Targeted PET for Prostate Cancer: From Radiotracer Development to First-in-Human Imaging
    Tais Basaco Bernabeu, Rosalba Mansi, Luigi Del Pozzo, Sandra Zanger, Raghuvir H. Gaonkar, Lisa McDougall, Francesco De Rose, Leila Jaafar-Thiel, Michael Herz, Matthias Eiber, Gary A. Ulaner, Wolfgang A. Weber, Melpomeni Fani
    Journal of Nuclear Medicine 2024 65 9
  • Radiocopper in Radiopharmacy and Medical Use: Current Status and Perspective
    Paweł Kręcisz, Katarzyna Stefańska, Jakub Studziński, Monika Pitucha, Agnieszka Czylkowska, Paweł Szymański
    Journal of Medicinal Chemistry 2025 68 3
  • Comparative analysis of positron emitters for theranostic applications based on small bioconjugates highlighting 43Sc, 61Cu and 45Ti
    Elif Hindié, Ulli Köster, Christophe Champion, Paolo Zanotti-Fregonara, Clément Morgat
    EJNMMI Physics 2024 11 1
  • Copper-61 is an advantageous alternative to gallium-68 for PET imaging of somatostatin receptor-expressing tumors: a head-to-head comparative preclinical study
    Tais Basaco Bernabeu, Rosalba Mansi, Luigi Del Pozzo, Raghuvir Haridas Gaonkar, Lisa McDougall, Anass Johayem, Milen Blagoev, Francesco De Rose, Leila Jaafar-Thiel, Melpomeni Fani
    Frontiers in Nuclear Medicine 2024 4
  • First-in-human administration of [61Cu]Cu-NODAGA-LM3 and head-to-head comparison with [68Ga]Ga-DOTA-TOC PET/CT as part of the phase I/II COPPER PET in NET study
    Guillaume P. Nicolas, Manuel Alejandre Lafont, Lisa McDougall, Felix Kaul, Alin Chirindel, Wolfgang Weber, Angela Llmazares, Anass Johayem, Markus Baier, Nicole Schubert, Francesco De Rose, Leila Jaafar-Thiel, Andreas Bauman, Melpomeni Fani, Damian Wild
    European Journal of Nuclear Medicine and Molecular Imaging 2025
  • How green are radiopharmaceutical sciences?
    Verena Pichler, Matthias Manfred Herth, Verena Hugenberg, Peter J.H. Scott, Sarah Spreckelmeyer, Sophie Stotz, Giancarlo Pascali
    Nuclear Medicine and Biology 2025 144-145
  • Is Copper-61 the New Gallium-68? Automation and Preclinical Proof-of-Concept of 61Cu-Based Radiopharmaceuticals for Prostate Cancer Imaging
    Diana Rodrigues, Alexandra I. Fonseca, Sérgio do Carmo, José Sereno, Ivanna Hrynchak, João N. Moreira, Célia Gomes, Antero Abrunhosa
    Pharmaceuticals 2025 18 4
  • Unveiling the potential of copper-61 vs. gallium-68 for SSTR PET imaging
    A. I. Fonseca, J. Sereno, S. Almeida, H. Ferreira, I. Hrynchak, A. Falcão, F. Alves, C. Gomes, A. J. Abrunhosa
    European Journal of Nuclear Medicine and Molecular Imaging 2025 52 7

Article usage

Article usage: October 2023 to April 2025

AbstractFullPdf
Oct 2023013944
Nov 2023015755
Dec 20230542136
Jan 2024029760
Feb 2024021142
Mar 2024013921
Apr 2024023227
May 2024010745
Jun 2024013627
Jul 2024026935
Aug 2024023039
Sep 202408832
Oct 202409631
Nov 202408324
Dec 202408028
Jan 202507636
Feb 2025012134
Mar 2025010427
Apr 2025013652
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 64 (12)
Journal of Nuclear Medicine
Vol. 64, Issue 12
December 1, 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
61Cu-Labeled Radiotracers: Alternative or Choice?
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
61Cu-Labeled Radiotracers: Alternative or Choice?
Melpomeni Fani, Guillaume P. Nicolas
Journal of Nuclear Medicine Dec 2023, 64 (12) 1855-1857; DOI: 10.2967/jnumed.123.266171

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
61Cu-Labeled Radiotracers: Alternative or Choice?
Melpomeni Fani, Guillaume P. Nicolas
Journal of Nuclear Medicine Dec 2023, 64 (12) 1855-1857; DOI: 10.2967/jnumed.123.266171
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • WHY 61CU VERSUS OTHER PET RADIONUCLIDES?
    • WHICH LIGANDS MAY BENEFIT FROM 61CU?
    • WHERE DO 61CU PRODUCTION, DISTRIBUTION, AND AVAILABILITY STAND?
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • Erratum
  • PubMed
  • Google Scholar

Cited By...

  • 61Cu-PSMA-Targeted PET for Prostate Cancer: From Radiotracer Development to First-in-Human Imaging
  • Google Scholar

More in this TOC Section

  • RECIP 1.0: A Roadmap for Clinical Implementation
  • Diagnostic Radiopharmaceutical Trial Design: Is It Time to Change Nomenclature?
  • From Stabilization to Depletion: Molecular Imaging to Measure Therapeutic Response in ATTR-CA
Show more Hot Topics

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire